Weight loss by treatment with Fugoa depot. Results of a double blind study
Muth, H.; Issmeier, G.
Therapie der Gegenwart 119(10): 1173-1183
1980
ISSN/ISBN: 0040-5965 PMID: 7008236 Document Number: 160744
Document emailed within 1 workday
Related Documents
Opala, T.; Rzymski, P.; Pischel, I.; Wilczak, M.; Wozniak, J. 2006: Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects--a randomised double-blind placebo-controlled clinical trial European Journal of Medical Research 11(8): 343-350Sonnenberg, A.; Lepsien, G.; Berges, W.; Weber, K.B.; Wienbeck, M.; Siewert, J.R.; Blum, A.L. 1979: Cimetidine treatment of reflux esophagitis: results of a double-blind study Schweizerische Medizinische Wochenschrift 109(16): 613-615
Eberl, R.; Dunky, A. 1983: Meclofenamate sodium in the treatment of acute gout. Results of a double-blind study Arzneimittel-Forschung 33(4a): 641-643
Gelenberg, A.J.; Doller, J.C. 1979: Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study Journal of Clinical Psychiatry 40(5): 238-240
Neumann-Mangoldt, P. 1979: Experiences in the use of Essaven capsules in the treatment of venous leg diseases. Results of a double-blind study Fortschritte der Medizin 97(45)
Haarmann, K.; Lebküchner, F.; Widmann, A.; Kief, W.; Esslinger, M. 1979: Symptomatic treatment of chronic postprandial complaints with Motilium (Domperidon): results of a double-blind study Die Medizinische Welt 30(8): 302-306
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Silny, W.; Czarnecka-Operacz, M. 2006: Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(126): 558-565
Bozza, A.E.; Guimarães, F.J.; de Carvalho, F.J.; Santos, L.C.; Pellon, F.M.; de Castro, R.F.; Balbuena, R.R. 1984: Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy Arquivos Brasileiros de Cardiologia 43(3): 213-217
Bauer, H.W.; Casarosa, C.; Cosci, M.; Fratta, M.; Blessmann, G. 1999: Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study MMW Fortschritte der Medizin 141(25): 62
Wolsko, P.M.; Eisenberg, D.M.; Simon, L.S.; Davis, R.B.; Walleczek, J.; Mayo-Smith, M.; Kaptchuk, T.J.; Phillips, R.S. 2004: Double-blind placebo-controlled trial of static magnets for the treatment of osteoarthritis of the knee: results of a pilot study Alternative Therapies in Health and Medicine 10(2): 36-43
Trnavský, K.; Fischer, M.; Vögtle-Junkert, U.; Schreyger, F. 2004: Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study Journal of Rheumatology 31(3): 565-572
Knothe, H.; Wettengel, R.; Feldmeier, W.; Primer, G. 1978: Treatment of chronic bronchitis with Supristol and a cotrimoxazole preparation--comparative bacteriological and clinical findings, results of a double-blind study Medizinische Klinik 73(50): 1780-1784
Visco, G. 1985: Polyunsaturated phosphatidylcholine in association with vitamin B complex in the treatment of acute viral hepatitis B. Results of a randomized double-blind clinical study La Clinica Terapeutica 114(3): 183-188
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399
Milewicz, A.; Gejdel, E.; Sworen, H.; Sienkiewicz, K.; Jedrzejak, J.; Teucher, T.; Schmitz, H. 1993: Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study Arzneimittel-Forschung 43(7): 752-756
Illig, R.; Exner, G.U.; Kollmann, F.; Kellerer, K.; Borkenstein, M.; Lunglmayr, L.; Kuber, W.; Prader, A. 1977: Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study Lancet 2(8037): 518-520
Rahman, K.M. 1975: Appetite stimulation and weight gain with cyproheptadine (periactin) in tuberculosis patients (double-blind clinical study) Medical Journal of Malaysia 29(4): 270-274
Duarte, C.; Baëhre, M.; Gharakhanian, S.; Leynadier, F. 2001: Treatment of severe seasonal rhinoconjunctivitis by a combination of azelastine nasal spray and eye drops: a double-blind, double-placebo study Journal of Investigational Allergology and Clinical Immunology 11(1): 34-40
Glogau, R.; Blitzer, A.; Brandt, F.; Kane, M.; Monheit, G.D.; Waugh, J.M. 2012: Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type a topical gel for the treatment of moderate-to-severe lateral canthal lines Journal of Drugs in Dermatology: Jdd 11(1): 38-45